Lynparza (olaparib), AstraZeneca’s PARP (poly ADP-ribose polymerase) inhibitor, has won approval as the primary treatment for high-risk early-stage breast cancer and metastatic, castration-resistant prostate cancer.Last Thursday, the Ministry of Food and Drug Safety approved Lynparza as adjuvant the
Celltrion said it signed a joint R&D contract with GeneMedicine, a Korean anticancer virus development company, to develop CT-P6 (ingredient: trastuzumab), a Herceptin biosimilar, into a new administration form.Under the contract, Celltrion will provide the raw material of CT-P6 for developing it in
Severance Hospital said its kidney transplantation team at the Organ Transplantation Center performed the 400th ABO incompatible kidney transplant on a patient suffering from hypertension and diabetes on Feb. 8.The hospital performed the first ABO incompatible kidney transplant in June 2010.Since th
PSMC will change its name to HLB innoVation at a shareholder meeting next month to emerge as the HLB Group’s key unit in developing CAR-T (chimeric antigen receptor-T cell) treatments. In a public disclosure on Friday, PSMC said it would change its corporate title to HLB innovation by holding an ext
GI Biome said on Monday that it won a substance and application patent for its anti-aging and senile sarcopenia improvement strain composition from the Korean Intellectual Property Office (KIPO).Sarcopenia refers to the decrease in the amount of muscle, muscle strength, and muscle function with age.
Celltrion has come forward to explain reasons for the delayed approval of its Humira biosimilar, Yuflyma (CT-P17), in the U.S., saying there were some problems, but they have been solved now.In a letter to shareholders published on its website Thursday, Celltrion said it has acquired a sales permit
Olympus, a global medical device company, said it plans to acquire Taewoong Medical, a Korean medical device maker specializing in gastroenterology and metal stents, for $370 million (about 482 billion won).Of the total acquisition payment, Olympus will pay approximately $255.5 million upon completi
Roche Korea recently decided to withdraw its Parkinson’s disease treatment Madopar Tab from the Korean market due to the appearance of a generic product and the consequent lowering of its price.However, the decision triggered patients’ moves calling for the drug’s resupply.According to the Ministry
Another oral option of a new mechanism has appeared in Korea’s ulcerative colitis (UC) market, saturated with various treatment options, ranging from injections such as TNF, interleukin, Integrin, and JAK inhibitors, to pills.On Thursday, the Ministry of Food and Drug Safety approved Zeposia Capsule
Merz Korea said it has relocated its office building from Samseong-dong to the 13th and 14th floors of Cheongdam Square in Cheongdam-dong, Gangnam-gu, Seoul, on Monday.The new Merz office focuses on a safer and more pleasant working environment based on ESG and a smart office function that allows em
Researchers at Severance Hospital have discovered a standard value to predict the incidence of complications and the association of mortality as a reference value for Asian patients receiving antiplatelet therapy after drug-releasing stent insertion.Drug-releasing stent insertion is performed to tre
The police said they arrested an employee of Samsung Biologics who tried to take out the company's classified data without permission.The Incheon Metropolitan Police Agency said Thursday that it is investigating the Samsung Biologics employee on charges of violating the Unfair Competition Prevention
Marie-Antoine Careme is the first celebrity chef in modern culinary. He brought French cuisine from the Middle Age to the modern age. Unfortunately, the life of genius chef Careme was too short. He died in 1834 at the age of only 48. It was because he had been working too long in a poorly ventilated
ATsens said on Friday that its real-time ECG patch, AT-patch, will be used in the “world’s first” clinical trial to evaluate the incidence and risk of arrhythmia in adults climbing Mount Everest in conjunction with a university hospital in Switzerland.The "Cardiac Arrhythmias at Extreme Altitude" cl
Macrogen, a Korean genome analysis company, said that it used its genetic testing technology to confirmed that 15 otters were living in the Han River area. Otters are a Class 1 endangered wildlife species.Macrogen and the Association of Korea Otter Conservation (AKOC) conducted the study to find out
A team of Korean researchers has revealed the function of the Dicer protein in generating microRNA (miRNA) for developing RNA therapeutics in two studies published simultaneously in the Nature journal.In particular, the first study highlighted how human dicer (hDICER) recognizes the precursor microR
Dongwon Industries, the holding company of Dongwon Group, said it has started its process to acquire Boryung Biopharma. Dongwon Industries, founded in April 1969, focuses on seafood products including tuna cans. Established in 1991, Boryung Biopharma is an affiliate of Boryung Group developing vacci
Oxyracetam drugs, brain function improvement treatments that failed to prove their efficacy in clinical re-evaluation, were exited from the market eventually.On Tuesday, the Ministry of Food and Drug Safety began to withdraw and discard oxiracetam treatments supplied by domestic drugmakers, saying t
Korea Biomedical Review is publishing a series of articles to analyze the top 10 Korean pharmaceutical and biopharma companies with the largest market capitalizations listed on the main bourse, Kospi, and the tech-heavy Kosdaq. The series aims to reflect key industrial issues and the flow of the cap
Hypoesthesia, one of the aftereffects of Covid-19, also causes neurological aftereffects, such as brain fog (vacancy) and memory loss, a study showed.Professor Jeong Young-hee of the Neurology Department at Myongji Hospital said so while releasing her analysis of 440 patients who visited the hospita